PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma.
Chenlu LanXinlei HuangXiwen LiaoXin ZhouKai PengYongguang WeiChuangye HanTao PengJianyao WangGuangzhi ZhuPublished in: Pharmacogenomics and personalized medicine (2023)
may be a prognostic biomarker and a underlying treatment target for HCC.